Abstracts

Citation

Mark Mirochnick, M.D., George E. Kafulafula, MMED, F.A.C.O.G., M.B.B.S., Regis Kreitchmann, M.D., Jorge Pinto, M.D., D.Sc., Teresa Parsons, Ph.D., Karin Alvarenga-Hyldgaard Nielsen, M.D., M.P.H., Paul Sato, M.D., M.P.H., Lynne M. Mofenson, M.D., F.A.A.P., Mary Glenn Fowler, M.D., M.P.H. Pharmacokinetics (PK) of Tenofovir Disoproxil Fumarate (TDF) After Administration to HIV-1 Infected Pregnant Women and their Newborns. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

George K. Siberry, M.D., M.P.H., Jorge Lujan-Zilbermann, M.D., Paige L. Williams, Ph.D., Meredith Warshaw, M.A., Michael Decker, M.D., M.P.H., Barbara E. Heckman, B.S., Emily Demske, B.A., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Patrick Jean-Philippe, M.D., Sharon Appelbaum Nachman, M.D. Immunogenicity of Quadrivalent Meningococcal Vaccine in HIV-infected Youth. Presented at: 16th Conference on Retroviruses & Opportunistic Infections; 2009 Feb 08.

Citation

Kumud K. Singh, Ping Ruan, Ph.D., Terence Fenton, Ed.D., Stephen A. Spector, M.D. HLA Class I and Class II Alleles Alter Disease Progression and CNS Impairment of HIV-Infected Children. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Avy Violari, M.D., Sharon Appelbaum Nachman, M.D., George D. McSherry, M.D., Mark F. Cotton, MMED, Ph.D., MB ChB, Raziya Bobat, M.D., Soyeon Kim, Ph.D., Patrick Jean-Philippe, M.D., Shabir A. Madhi, M.D., Charles Debeaux Mitchell, M.D. Causes of Morbidity and Mortality in HIV Infected and HIV Uninfected Children from the IMPAACT P1041 Trial. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Heather Ribaudo, Ph.D., Jeffrey L. Lennox, M.D., Judith Silverstein Currier, M.D., M.Sc., Daniel R. Kuritzkes, M.D., Richard H. Haubrich, M.D., Sharon A. Riddler, M.D., M.P.H., Michael Hughes, Ph.D. Virologic failure definition (VFD) in clinical trials: Is using HIV-1 RNA (VL) threshold 200 copies/ml (c/ml) better than 50 c/ml?. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Adriana Weinberg, M.D., Sharon Huang, M.S., Terence Fenton, Ed.D., Julie A. Patterson, B.S., Philimon Gona, Ph.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Wayne M. Dankner, M.D., Sharon Appelbaum Nachman, M.D. Factors Associated with Robust Antibody Responses to the Hepatitis A Virus (HAV) Vaccine in HIV-Infected Children: IMPAACT P1008. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Susan Brogly, Ph.D., Marc Foca, M.D., Jaime G. Deville, M.D., Mark Mirochnick, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H, Rolando M. Viani, M.D., M.T.P., Sandra K. Burchett, M.D., M.S., Renee Browning, R.N., M.S.N, Ellen Rae Cooper, M.P.H., M.D. Potential confounding of the association between exposure to neucleoside analogues and mitochondrial dysfunction in HIV-uninfected and indeterminate infants. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Kumud K. Singh, Ping Ruan, Ph.D., Terence Fenton, Ed.D., Yan Wang, Rodney Trout, B.S., Stephen A. Spector, M.D. APOBEC3G-186H/R and 119F/F Variants are Associated with HIV-1 Disease Progression and CNS Impairment in children. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Karin Alvarenga-Hyldgaard Nielsen, M.D., M.P.H., Mark Mirochnick, M.D., M. Ines Boechat, M.D., F.A.C.R., George E. Kafulafula, MMED, F.A.C.O.G., M.B.B.S., Regis Kreitchmann, M.D., Jorge Pinto, M.D., D.Sc., Molly Swenson, Paul Sato, M.D., M.P.H., Lynne M. Mofenson, M.D., F.A.A.P. Bone Age and Mineral Density Assessments Using Plain Roentgenograms in Tenofovir (TDF) exposed infants in Malawi and Brazil. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.

Citation

Edmund Capparelli, Pharm.D., Brian Robbins, Ph.D., Mobeen H. Rathore, M.D., Paula Britto, M.S., ChengCheng Hu, Ph.D., Adriana Weinberg, M.D., Renee Browning, R.N., M.S.N, Rohan Hazra, M.D., Ross E. McKinney, Jr., M.D., Michael Rochon-Duck. Age-Related Pharmacokinetics of Efavirenz Solution. Presented at: 16th Conference on Retroviruses & Opportunistic Infections.